Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RS4B
|
|||
| Former ID |
DNC013940
|
|||
| Drug Name |
FGGFTGARKSARKVANQ
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C78H127N27O22
|
|||
| Canonical SMILES |
CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N
|
|||
| InChI |
1S/C78H127N27O22/c1-40(2)61(75(125)95-43(5)65(115)102-54(35-57(83)109)71(121)101-52(76(126)127)27-28-56(82)108)104-70(120)49(24-14-16-30-80)100-68(118)51(26-18-32-89-78(86)87)98-64(114)42(4)94-73(123)55(39-106)103-69(119)48(23-13-15-29-79)99-67(117)50(25-17-31-88-77(84)85)97-63(113)41(3)93-59(111)38-92-74(124)62(44(6)107)105-72(122)53(34-46-21-11-8-12-22-46)96-60(112)37-90-58(110)36-91-66(116)47(81)33-45-19-9-7-10-20-45/h7-12,19-22,40-44,47-55,61-62,106-107H,13-18,23-39,79-81H2,1-6H3,(H2,82,108)(H2,83,109)(H,90,110)(H,91,116)(H,92,124)(H,93,111)(H,94,123)(H,95,125)(H,96,112)(H,97,113)(H,98,114)(H,99,117)(H,100,118)(H,101,121)(H,102,115)(H,103,119)(H,104,120)(H,105,122)(H,126,127)(H4,84,85,88)(H4,86,87,89)/t41-,42-,43-,44+,47-,48-,49-,50-,51-,52-,53-,54-,55-,61-,62-/m0/s1
|
|||
| InChIKey |
PLDGJAGJBNNRQP-OTYLYHRBSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Nociceptin receptor (OPRL1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
| Reactome | Peptide ligand-binding receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Peptide GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synergistic effect of basic residues at positions 14-15 of nociceptin on binding affinity and receptor activation. Bioorg Med Chem. 2008 Oct 15;16(20):9261-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.